X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3731) 3731
Book Review (546) 546
Publication (450) 450
Book Chapter (122) 122
Conference Proceeding (35) 35
Dissertation (9) 9
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
α-synuclein (3441) 3441
index medicus (2510) 2510
alpha-synuclein (2343) 2343
humans (1810) 1810
parkinson's disease (1778) 1778
neurosciences (1544) 1544
parkinsons-disease (1206) 1206
animals (1139) 1139
alpha-synuclein - metabolism (1118) 1118
parkinson’s disease (775) 775
biochemistry & molecular biology (739) 739
lewy bodies (734) 734
male (649) 649
alzheimers-disease (640) 640
neurodegeneration (603) 603
alpha-synuclein - genetics (573) 573
mice (563) 563
clinical neurology (538) 538
parkinson disease - metabolism (520) 520
aggregation (494) 494
female (485) 485
pathology (464) 464
oxidative stress (461) 461
neurodegenerative diseases (459) 459
mutation (418) 418
aged (414) 414
neurology (397) 397
α‐synuclein (397) 397
nervous system diseases (393) 393
nervous system (390) 390
proteins (384) 384
parkinson disease - pathology (383) 383
dementia (367) 367
multiple system atrophy (362) 362
synuclein (359) 359
brain (353) 353
alpha-synuclein - chemistry (345) 345
synucleins (344) 344
neurons - metabolism (340) 340
parkinson disease - genetics (336) 336
dopamine (332) 332
brain - metabolism (328) 328
middle aged (324) 324
cell biology (314) 314
neurons (313) 313
in-vitro (312) 312
article (307) 307
rats (306) 306
protein (283) 283
brain - pathology (277) 277
alzheimer's disease (265) 265
immunohistochemistry (257) 257
nerve tissue proteins - metabolism (256) 256
aged, 80 and over (253) 253
disease models, animal (251) 251
substantia-nigra (248) 248
tau (248) 248
autophagy (230) 230
parkinson disease (230) 230
phosphorylation (226) 226
neurons - pathology (221) 221
lewy body (220) 220
biophysics (219) 219
mice, inbred c57bl (219) 219
movement disorders (204) 204
pathogenesis (198) 198
expression (194) 194
mice, transgenic (190) 190
dementia with lewy bodies (178) 178
lewy body disease (174) 174
analysis (172) 172
cell line, tumor (172) 172
nerve tissue proteins - genetics (171) 171
dopamine - metabolism (170) 170
apoptosis (169) 169
lewy bodies - pathology (169) 169
protein aggregation (169) 169
amyloid (167) 167
toxicity (165) 165
biomedicine (164) 164
oligomers (162) 162
lewy bodies - metabolism (161) 161
neurodegenerative disorders (160) 160
parkin (160) 160
transgenic mice (160) 160
cells, cultured (158) 158
animal diseases (155) 155
pharmacology & pharmacy (153) 153
disease (151) 151
parkinson disease - physiopathology (151) 151
cell-death (148) 148
neurotoxicity (148) 148
mental disorders (147) 147
lewy body disease - pathology (146) 146
mouse model (146) 146
protein binding (146) 146
dopaminergic-neurons (141) 141
medicine & public health (139) 139
mitochondria (139) 139
parkinsons disease (137) 137
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3771) 3771
Japanese (27) 27
Korean (10) 10
German (7) 7
French (5) 5
Chinese (4) 4
Spanish (3) 3
Polish (2) 2
Dutch (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 10/2017, Volume 37, Issue 40, pp. 9617 - 9631
Journal Article
03/2011
α-Synuclein is an abundant nerve terminal protein and a primary component of the Lewy body pathology seen in Parkinson’s disease. While the precise biological... 
Rab3a | α-Synuclein | Parkinson's disease | 0317
Dissertation
BBA - Proteins and Proteomics, ISSN 1570-9639, 10/2019, Volume 1867, Issue 10, pp. 890 - 908
α-Synuclein (α-Syn) has been extensively studied for its structural and biophysical properties owing to its pathophysiological role in Parkinson’s disease... 
Aggregation | α-Synuclein | Amyloid | Parkinson’s disease
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 05/2013, Volume 125, Issue 5, pp. 753 - 769
We report a British family with young-onset Parkinson's disease (PD) and a G51D SNCA mutation that segregates with the disease. Family history was consistent... 
Multiple system atrophy | α-Synuclein | Parkinson's disease | SNCA | Atrophy | Ubiquitin | Family | Genetic aspects | Dopa
Journal Article
Experimental Neurology, ISSN 0014-4886, 09/2016, Volume 283, pp. 213 - 223
Synucleinopathy is characterized by abnormal accumulation of misfolded α-synuclein (α-Syn)-positive cytoplasmic inclusions and by neurodegeneration and... 
α-Synuclein | receptor | Synucleinopathy | Hippocampus | Adenosine A
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 04/2015, Volume 112, Issue 15, pp. E1926 - E1935
Journal Article
Neuropathology and Applied Neurobiology, ISSN 0305-1846, 02/2016, Volume 42, Issue 1, pp. 77 - 94
Journal Article
Journal of Neuroscience Methods, ISSN 0165-0270, 01/2019, Volume 311, pp. 89 - 94
Protein aggregation in neurons is a prominent pathological mark of neurodegeneration. In Parkinson’s disease (PD), inclusions of the α-Synuclein (α-Syn)... 
α-Synuclein | CNS | Neurodegeneration | Drosophila | Parkinson’s disease
Journal Article
Neurobiology of disease, ISSN 0969-9961, 8/2018, Volume 116, pp. 53 - 59
Plasma total and nervous system derived exosomal (NDE) α-synuclein have been determined as potential biomarkers of Parkinson’s disease (PD). To explore the... 
Plasma | α-Synuclein | Risk | Parkinson’s | Prodromal
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 07/2019, Volume 115, p. 108843
Many neurodegenerative diseases are characterized by progressive loss of neurons and abnormal protein accumulation, including amyloid (A)β and tau in... 
α-Synuclein | Monoclonal antibody | Immunotherapy | Parkinson’s disease
Journal Article
Neuroscience Letters, ISSN 0304-3940, 10/2019, Volume 711, pp. 134437 - 134437
Parkinson’s disease (PD) is characterised pathologically by degeneration of the dopaminergic (DA) neurones of the substantia nigra pars compacta (SNpc) and the... 
Trichloroethylene | α-Synuclein | TaClo | Neurodegeneration | Parkinson’s disease | Index Medicus
Journal Article
Biological Psychiatry, ISSN 0006-3223, 05/2019, Volume 85, Issue 9, pp. 769 - 781
Death-associated protein kinase 1 (DAPK1) is a widely distributed serine/threonine kinase that is critical for cell death in multiple neurological disorders,... 
α-Synuclein | miRNA | MPTP | DAPK1 | Peptide | Parkinson’s disease
Journal Article
Brain Research, ISSN 0006-8993, 07/2019, Volume 1715, pp. 203 - 212
The dopaminergic neurodegeneration in the substantia nigra (SN ) and striatum of the midbrain is the important pathological feature of Parkinson's disease... 
α-Synuclein | Apelin-13 | Autophagy | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridin | Parkinson’s disease | Endoplasmic reticulum stress
Journal Article
Toxicology Letters, ISSN 0378-4274, 01/2017, Volume 265, pp. 30 - 37
Parkinson’s disease (PD) is characterized by α-synuclein accumulation, dopaminergic neuron loss and inflammation. α-Synuclein can be secreted by neurons and... 
Inflammation | α-synuclein | Parkinson’s disease | Microglia
Journal Article
Trends in Neurosciences, ISSN 0166-2236, 02/2019, Volume 42, Issue 2, pp. 140 - 149
The discovery of genetic forms of Parkinson’s disease (PD) has highlighted the importance of the autophagy/lysosomal and mitochondrial/oxidative stress... 
αSynuclein | oxidized dopamine | synaptic vesicle endocytosis | genetics | Parkinson’s disease
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2018, Volume 115, Issue 51, pp. E12053 - E12062
Journal Article
Trends in Neurosciences, ISSN 0166-2236, 01/2019, Volume 42, Issue 1, pp. 4 - 13
We hypothesize that Parkinson’s disease (PD) pathogenesis can be divided into three temporal phases. During the first phase, ‘triggers’, such as viral... 
clinical trials | genetics | inflammation | Parkinson’s disease | α-synuclein
Journal Article